Saxa
Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic of the dipeptidyl peptidase-4 inhibitor class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug.
⚠️ Products listed on this site are from Shopify independent sellers, not official brand sales. Please verify authenticity on your own.
No products found
Try another brand or browse our collections.